Intelligent Bio Valuation
| INBS Stock | USD 1.76 0.18 11.39% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Intelligent Bio Solutions retains a regular Real Value of $1.34 per share. The prevalent price of the firm is $1.76. Our model calculates the value of Intelligent Bio Solutions from evaluating the firm fundamentals such as Return On Asset of -0.53, shares outstanding of 4.39 M, and Return On Equity of -1.72 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Intelligent Bio's valuation include:
Price Book 1.2442 | Enterprise Value | Enterprise Value Ebitda (0.91) | Price Sales 2.4408 | Enterprise Value Revenue 1.3849 |
Overvalued
Today
Please note that Intelligent Bio's price fluctuation is extremely dangerous at this time. Calculation of the real value of Intelligent Bio Solutions is based on 3 months time horizon. Increasing Intelligent Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Intelligent stock is determined by what a typical buyer is willing to pay for full or partial control of Intelligent Bio Solutions. Since Intelligent Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Intelligent Stock. However, Intelligent Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.76 | Real 1.34 | Target 11.3 | Hype 1.58 | Naive 1.63 |
The intrinsic value of Intelligent Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Intelligent Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Intelligent Bio Solutions helps investors to forecast how Intelligent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Intelligent Bio more accurately as focusing exclusively on Intelligent Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Intelligent Bio's intrinsic value based on its ongoing forecasts of Intelligent Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Intelligent Bio's closest peers.
Intelligent Bio Cash |
|
Intelligent Valuation Trend
Intelligent Bio's real value is important for investors to make better decisions and a more accurate overall view of Intelligent Bio's financial worth over time. Using both Intelligent Bio's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Intelligent Bio Total Value Analysis
Intelligent Bio Solutions is currently forecasted to have valuation of 4.42 M with market capitalization of 6.14 M, debt of 871.44 K, and cash on hands of 8.28 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Intelligent Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.42 M | 6.14 M | 871.44 K | 8.28 M |
Intelligent Bio Investor Information
About 14.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.24. Some equities with similar Price to Book (P/B) outperform the market in the long run. Intelligent Bio Solutions recorded a loss per share of 2.3. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 29th of January 2024. Based on the analysis of Intelligent Bio's profitability, liquidity, and operating efficiency, Intelligent Bio Solutions is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Intelligent Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Intelligent Bio has an asset utilization ratio of 22.58 percent. This implies that the Company is making $0.23 for each dollar of assets. An increasing asset utilization means that Intelligent Bio Solutions is more efficient with each dollar of assets it utilizes for everyday operations.Intelligent Bio Ownership Allocation
Intelligent Bio retains 3.01 (percent) of its outstanding shares held by insiders and 14.38 (percent) owned by outside corporations.Intelligent Bio Profitability Analysis
The company reported the previous year's revenue of 3.11 M. Net Loss for the year was (10.19 M) with profit before overhead, payroll, taxes, and interest of 326.67 K.About Intelligent Bio Valuation
The stock valuation mechanism determines Intelligent Bio's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Intelligent Bio Solutions based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intelligent Bio. We calculate exposure to Intelligent Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Intelligent Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.6 M | 862.7 K | |
| Pretax Profit Margin | (2.95) | (3.09) | |
| Operating Profit Margin | (2.97) | (3.12) | |
| Net Loss | (2.94) | (3.08) | |
| Gross Profit Margin | 0.41 | 0.29 |
Intelligent Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Intelligent Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.6 M |
Intelligent Bio Current Valuation Indicators
Intelligent Bio's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Intelligent Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Intelligent Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Intelligent Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Intelligent Bio's worth.Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.